Literature DB >> 1713578

Interleukin-2 receptor regulates activation of phosphatidylinositol 3-kinase.

B Remillard1, R Petrillo, W Maslinski, M Tsudo, T B Strom, L Cantley, L Varticovski.   

Abstract

Interleukin-2 (IL-2) stimulates proliferation of T lymphocytes and is involved in the activation of both natural killer and lymphokine-activated killer precursor cells. The intracellular messengers which mediate IL-2-dependent events have not yet been identified. IL-2 receptor is not a protein-tyrosine kinase. Activation of a cellular protein-tyrosine kinase and direct association of a protein-tyrosine kinase activity with the IL-2 receptor occurs within minutes of IL-2 stimulation. We investigated the activation of phosphatidylinositol 3-kinase (PI 3-kinase) in IL-2-mediated signal transduction using the IL-2-dependent murine T-cell line, CTLL-2, and human phytohemagglutinin-stimulated peripheral blood lymphocytes (phytohemagglutinin blasts). Within a minute following stimulation of these cells with IL-2, PI 3-kinase activity could be detected in antiphosphotyrosine (anti-P-Tyr) antibody immunoprecipitates. IL-2 triggered a direct association of PI 3-kinase with the IL-2 receptor as detected in immunoprecipitates using anti-IL-2 receptor beta chain antibody. In vivo labeled CTLL-2 cells have a time-dependent increase in D-3-phosphorylated polyphosphoinositides following stimulation with IL-2. This is the first group of second messengers identified in IL-2-mediated signal transduction.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1713578

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  A human class II MHC-derived peptide antagonizes phosphatidylinositol 3-kinase to block IL-2 signaling.

Authors:  M L Boytim; P Lilly; K Drouvalakis; S C Lyu; R Jung; A M Krensky; C Clayberger
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

Review 2.  Cytokine receptors: structure and signal transduction.

Authors:  B M Foxwell; K Barrett; M Feldmann
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

Review 3.  Immunobiology and immunopharmacology of organ allograft rejection.

Authors:  M Suthanthiran; T B Strom
Journal:  J Clin Immunol       Date:  1995-07       Impact factor: 8.317

4.  Akt2 inhibits the activation of NFAT in lymphocytes by modulating calcium release from intracellular stores.

Authors:  Victoria A Martin; Wen-Horng Wang; Andrew M Lipchik; Laurie L Parker; Yantao He; Sheng Zhang; Zhong-Yin Zhang; Robert L Geahlen
Journal:  Cell Signal       Date:  2012-01-11       Impact factor: 4.315

5.  Selective effects of PD-1 on Akt and Ras pathways regulate molecular components of the cell cycle and inhibit T cell proliferation.

Authors:  Nikolaos Patsoukis; Julia Brown; Victoria Petkova; Fang Liu; Lequn Li; Vassiliki A Boussiotis
Journal:  Sci Signal       Date:  2012-06-26       Impact factor: 8.192

6.  Reconstitution of functional interleukin 2 receptor complexes on fibroblastoid cells: involvement of the cytoplasmic domain of the gamma chain in two distinct signaling pathways.

Authors:  H Asao; T Takeshita; N Ishii; S Kumaki; M Nakamura; K Sugamura
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

7.  Activation of phosphatidylinositol 3-kinase by epidermal growth factor, basic fibroblast growth factor, and nerve growth factor in PC12 pheochromocytoma cells.

Authors:  S Raffioni; R A Bradshaw
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

8.  Activation of phosphatidylinositol-3 kinase by ligation of the interleukin-7 receptor on human thymocytes.

Authors:  H K Dadi; C M Roifman
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

9.  Src-homology 3 domain of protein kinase p59fyn mediates binding to phosphatidylinositol 3-kinase in T cells.

Authors:  K V Prasad; O Janssen; R Kapeller; M Raab; L C Cantley; C E Rudd
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

10.  Nuclear Phosphoproteomic Screen Uncovers ACLY as Mediator of IL-2-induced Proliferation of CD4+ T lymphocytes.

Authors:  Nerea Osinalde; Jone Mitxelena; Virginia Sánchez-Quiles; Vyacheslav Akimov; Kerman Aloria; Jesus M Arizmendi; Ana M Zubiaga; Blagoy Blagoev; Irina Kratchmarova
Journal:  Mol Cell Proteomics       Date:  2016-04-11       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.